| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.
|
Kidney Int
|
2009
|
7.45
|
|
2
|
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.
|
Kidney Int
|
2009
|
7.19
|
|
3
|
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults.
|
Kidney Int
|
2010
|
2.14
|
|
4
|
Suppressors of cytokine signaling abrogate diabetic nephropathy.
|
J Am Soc Nephrol
|
2010
|
2.02
|
|
5
|
Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?
|
Kidney Int
|
2005
|
1.67
|
|
6
|
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.
|
Kidney Int Suppl
|
2002
|
1.65
|
|
7
|
Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.
|
J Am Soc Nephrol
|
2004
|
1.55
|
|
8
|
Co-regulation of Gremlin and Notch signalling in diabetic nephropathy.
|
Biochim Biophys Acta
|
2007
|
1.44
|
|
9
|
Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats.
|
J Pharmacol Exp Ther
|
2005
|
1.43
|
|
10
|
The MIF receptor CD74 in diabetic podocyte injury.
|
J Am Soc Nephrol
|
2008
|
1.22
|
|
11
|
Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.
|
Am J Kidney Dis
|
2005
|
1.21
|
|
12
|
Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation.
|
PLoS One
|
2009
|
1.12
|
|
13
|
Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.
|
PLoS One
|
2010
|
1.01
|
|
14
|
Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways.
|
Pharm Res
|
2008
|
1.01
|
|
15
|
Renal expression of angiotensin type 2 (AT2) receptors during kidney damage.
|
Kidney Int Suppl
|
2003
|
1.01
|
|
16
|
Angiotensin II increases connective tissue growth factor in the kidney.
|
Am J Pathol
|
2003
|
1.00
|
|
17
|
Expression of Smac/Diablo in tubular epithelial cells and during acute renal failure.
|
Kidney Int Suppl
|
2003
|
0.98
|
|
18
|
HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II.
|
Lab Invest
|
2011
|
0.94
|
|
19
|
Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response.
|
Kidney Int Suppl
|
2003
|
0.93
|
|
20
|
TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
|
Kidney Int
|
2012
|
0.89
|
|
21
|
Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats.
|
J Hypertens
|
2007
|
0.88
|
|
22
|
Fn14 in podocytes and proteinuric kidney disease.
|
Biochim Biophys Acta
|
2013
|
0.87
|
|
23
|
Long-term blood pressure control prevents oxidative renal injury.
|
Antioxid Redox Signal
|
2005
|
0.86
|
|
24
|
IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosis.
|
J Am Soc Nephrol
|
2008
|
0.86
|
|
25
|
Angiotensin II contributes to renal fibrosis independently of Notch pathway activation.
|
PLoS One
|
2012
|
0.85
|
|
26
|
Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells.
|
Nephron Exp Nephrol
|
2013
|
0.84
|
|
27
|
Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II.
|
J Renin Angiotensin Aldosterone Syst
|
2006
|
0.79
|
|
28
|
Antihypertensive and renoprotective effect of the kinin pathway activated by potassium in a model of salt sensitivity following overload proteinuria.
|
Am J Physiol Renal Physiol
|
2013
|
0.78
|
|
29
|
Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
|
Nephrol Dial Transplant
|
2008
|
0.78
|
|
30
|
The health system in Chile: the nephrologist perspective.
|
J Nephrol
|
2011
|
0.77
|
|
31
|
Effect of mycophenolate mofetil on kallikrein expression in the kidney of 5/6 nephrectomized rats.
|
Kidney Blood Press Res
|
2002
|
0.77
|
|
32
|
Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy.
|
FEBS J
|
2013
|
0.77
|
|
33
|
Prevention strategies for chronic kidney disease in Latin America: a strategy for the next decade--a report on the Villarica Conference.
|
Ren Fail
|
2006
|
0.77
|
|
34
|
[Achilles tendinitis associated to levofloxacin: report of 4 cases].
|
Rev Med Chil
|
2002
|
0.76
|
|
35
|
Translational study of the Notch pathway in hypertensive nephropathy.
|
Nefrologia
|
2014
|
0.76
|
|
36
|
Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats.
|
Nephrol Dial Transplant
|
2006
|
0.75
|
|
37
|
[Role of the kidney in salt sensitive hypertension].
|
Rev Med Chil
|
2010
|
0.75
|
|
38
|
Prevention strategies for chronic disease in Latin America.
|
Nat Clin Pract Nephrol
|
2006
|
0.75
|
|
39
|
Renal health in Chile.
|
Ren Fail
|
2006
|
0.75
|
|
40
|
Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney.
|
J Nephrol
|
2006
|
0.75
|
|
41
|
[Diabetic renal disease: the World Kidney Day in Chile].
|
Rev Med Chil
|
2010
|
0.75
|
|
42
|
[Vascular damage in chronic kidney disease].
|
Rev Med Chil
|
2008
|
0.75
|
|
43
|
[Antiphospholipid antibodies in idiopathic membranous nephropathy].
|
Rev Med Chil
|
2005
|
0.75
|